Souhaitez-vous accéder aux communiqués récents ?

Existing Steakholder Shareholders to Retain Majority Stake; Twine Shareholders Previously Invested in Steakholder and Provided Convertible Loan, Both at a Substantial Premium Strategic Acquisition...

All 27 patients completed treatment with no serious adverse events, underscoring a favorable safety profileStatistically significant improvements achieved across all efficacy endpoints at the 4-week...

The U.S. housing crisis isn’t just a matter of construction delays or red tape. The problem begins before the first shovel hits dirt.

WATERTOWN, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of...

Highlights Independent institutional experience shows archival cytology slides enabled successful molecular results in cases previously insufficient for testing by another commercially available...

HONG KONG, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Inno Holdings Inc. (NASDAQ: INHD) (the “Company”), a trade-focused building technology and electronic products trading company, today announced the...

HONG KONG, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Inno Holdings Inc. (NASDAQ: INHD) (the “Company”), a trade-focused building technology and electronic products trading company, today announced that it...

GUANGZHOU, CHINA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Youxin Technology Ltd (NASDAQ: YAAS) (the “Company”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to...

GUANGZHOU, CHINA, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Youxin Technology Ltd (NASDAQ: YAAS) (the “Company”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to...

- Transformational deal for CorMedix that expands and diversifies company’s commercial product portfolio, with seven innovative drug products and a pipeline expansion indication with near-term revenue...